{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:55:07Z","timestamp":1791946507394,"version":"4.3.4"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Interleukin-18 (IL-18), a pro-inflammatory cytokine belonging to the IL-1 Family, is a key mediator ofautoinflammatory diseases associated with the development of macrophage activation syndrome (MAS).High levels of IL-18 correlate with MAS and COVID-19 severity and mortality, particularly in COVID-19patients with MAS. As an inflammation inducer, IL-18 binds its receptor IL-1 Receptor 5 (IL-1R5), leadingto the recruitment of the co-receptor, IL-1 Receptor 7 (IL-1R7). This heterotrimeric complex subsequentlyinitiates downstream signaling, resulting in local and systemic inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reported earlier the development of a novel humanized monoclonal anti-human IL-1R7 antibody whichspecifically blocks the activity of human IL-18 and its inflammatory signaling in human cell and wholeblood cultures. In the current study, we further explored the strategy of blocking IL-1R7 inhyperinflammation in vivo using animal models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We first identified an anti-mouse IL-1R7 antibody that significantly suppressed mouse IL-18 andlipopolysaccharide (LPS)-induced IFNg production in mouse splenocyte and peritoneal cell cultures. Whenapplied in vivo, the antibody reduced Propionibacterium acnes and LPS-induced liver injury and protectedmice from tissue and systemic hyperinflammation. Importantly, anti-IL-1R7 significantly inhibited plasma,liver cell and spleen cell IFNg production. Also, anti-IL-1R7 downregulated plasma TNFa, IL-6, IL-1b,MIP-2 production and the production of the liver enzyme ALT. In parallel, anti-IL-1R7 suppressed LPSinducedinflammatory cell infiltration in lungs and inhibited the subsequent IFNg production andinflammation in mice when assessed using an acute lung injury model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Altogether, our data suggest that blocking IL-1R7 represents a potential therapeutic strategy to specificallymodulate IL-18-mediated hyperinflammation, warranting further investigation of its clinical application intreating IL-18-mediated diseases, including MAS and COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1427100","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T04:45:00Z","timestamp":1719290700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation"],"prefix":"10.3389","volume":"15","author":[{"given":"Liqiong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars P.","family":"Lunding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Falkesgaard H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Amo-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Pessara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Parera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Orlicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces interferon-g","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"B3","article-title":"Interleukin-18, a proinflammatory cytokine","volume":"11","author":"Dinarello","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/386619a0","article-title":"Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production","volume":"386","author":"Ghayur","year":"1997","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.jbc.2021.100630","article-title":"A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling","volume":"296","author":"Li","year":"2021","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ibd.20272","article-title":"Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease","volume":"14","author":"Leach","year":"2008","journal-title":"Inflammation Bowel Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"155302","DOI":"10.1016\/j.cyto.2020.155302","article-title":"Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19","volume":"137","author":"Satis","year":"2020","journal-title":"Cytokine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26589","article-title":"Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome","volume":"93","author":"Kerget","year":"2020","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.212519099","article-title":"A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity","volume":"99","author":"Bufler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.09.009","article-title":"Anti-inflammatory activity of IL-37 in asthmatic children: Correlation with inflammatory cytokines TNF-alpha, IL-beta, IL-6 and IL-17A","volume":"221","author":"Charrad","year":"2016","journal-title":"Immunobiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","article-title":"Interleukin-37 expression is decreased in Behcet's disease and is associated with inflammation","volume":"167","author":"Bouali","year":"2015","journal-title":"Immunol Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1354367","article-title":"Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis","volume":"34","author":"Jiang","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2100","article-title":"Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein","volume":"170","author":"Banda","year":"2003","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nold-Petry","year":"2015","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607917103","article-title":"Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor","volume":"103","author":"Lewis","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.004184","article-title":"Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling","volume":"284","author":"Nold-Petry","year":"2009","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.148","article-title":"Functional reconstitution and regulation of IL-18 activity by the IL- 18R beta chain","volume":"166","author":"Kim","year":"2001","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80163-5","article-title":"Regulation of interferon-gamma production by IL-12 and IL-18","volume":"10","author":"Okamura","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.2256","article-title":"Gene expression, synthesis and secretion of IL-1b and IL-18 are differentially regulated in human blood mononuclear cells and mouse spleen cells","volume":"96","author":"Puren","year":"1999","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1086\/314481","article-title":"Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures","volume":"178","author":"Puren","year":"1998","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0467-1","article-title":"IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease","volume":"20","author":"Hojen","year":"2019","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.24.12161-12168.2001","article-title":"Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1","volume":"75","author":"Hezareh","year":"2001","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.10.3966-3972.1995","article-title":"A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock","volume":"63","author":"Okamura","year":"1995","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i17.3043","article-title":"Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury","volume":"23","author":"Qin","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.celrep.2019.10.042","article-title":"Intestinal IL-17R signaling constrains IL-18-Driven liver inflammation by the regulation of microbiome-Derived products","volume":"29","author":"Castillo-Dela Cruz","year":"2019","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94427","article-title":"Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice","volume":"128","author":"Lanaspa","year":"2018","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family","volume":"103","author":"Dinarello","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-012-1409-3","article-title":"Interleukin-18 levels reflect the long-term prognosis of acute lung injury and acute respiratory distress syndrome","volume":"26","author":"Makabe","year":"2012"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0003OC","article-title":"Inflammasome-regulated cytokines are critical mediators of acute lung injury","volume":"185","author":"Dolinay","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.09.007","article-title":"Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency","volume":"65","author":"Wada","year":"2014","journal-title":"Cytokine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40635-022-00488-x","article-title":"Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients","volume":"11","author":"Nasser","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.3390\/ijms241311125","article-title":"IL-18 in autoinflammatory diseases: focus on adult onset still disease and macrophages activation syndrome","volume":"24","author":"Baggio","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2019.008","article-title":"Soluble ST2 and CD163 as potential biomarkers to differentiate primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome","volume":"11","author":"Gao","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4095-1","article-title":"Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature","volume":"37","author":"Sonmez","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez284","article-title":"IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.5.1281","article-title":"Antibodies to interleukin 12 abrogate established experimental colitis in mice","volume":"182","author":"Neurath","year":"1995","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.281.4.R1264","article-title":"Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-g and TNF-a production","volume":"281","author":"Siegmund","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03214.x","article-title":"Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice","volume":"146","author":"Ito","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.29579","article-title":"Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice","volume":"121","author":"Ten Hove","year":"2001","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.6.812","article-title":"Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage","volume":"50","author":"Sivakumar","year":"2002","journal-title":"Gut"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.06.217","article-title":"IL-18 binding protein: a novel biomarker in obesity-related atherosclerosis that modulates lipoprotein metabolism","volume":"287","author":"van den Munckhof","year":"2019","journal-title":"Atherosclerosis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1086\/374751","article-title":"Interleukin-18 and host defense against infection","author":"Dinarello","year":"2003","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.12.7727","article-title":"The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)","volume":"272","author":"Wesche","year":"1997","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.12829","article-title":"Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein","volume":"94","author":"Huang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1129","article-title":"Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice","volume":"189","author":"Kanakaraj","year":"1999","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-010-0067-3","article-title":"Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature","volume":"39","author":"Kampitak","year":"2011","journal-title":"Infection"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512123132403","article-title":"Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production","volume":"313","author":"Murray","year":"1985","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-3-199508010-00009","article-title":"Interferon-gamma in the management of infectious diseases","volume":"123","author":"Gallin","year":"1995","journal-title":"Ann Intern Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1128\/iai.61.1.64-70.1993","article-title":"Purification of a factor which provides a costimulatory signal for gamma interferon production","volume":"61","author":"Nakamura","year":"1993","journal-title":"Infect Immun"},{"key":"B73","article-title":"Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis","volume":"39","author":"Tsutsui","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxp122","article-title":"IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes","volume":"22","author":"Kawa","year":"2010","journal-title":"Int Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00870-z","article-title":"Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity","volume":"22","author":"Flament","year":"2021","journal-title":"Nat Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: A new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41232-020-00131-w","article-title":"Macrophage activation syndrome and COVID-19","volume":"40","author":"Otsuka","year":"2020","journal-title":"Inflammation Regener"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.03.002","article-title":"Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes","volume":"59","author":"Canna","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3903","article-title":"A case of delayed COVID-19-related macrophage activation syndrome","volume":"13","author":"Abdelgabar","year":"2022","journal-title":"J Med cases"},{"key":"B85","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2025501","article-title":"Genetic risk of severe Covid-19","volume":"383","author":"Kaser","year":"2020","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12916-020-01682-y","article-title":"Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases","volume":"18","author":"Opoka-Winiarska","year":"2020","journal-title":"BMC Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0613-1","article-title":"Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection","volume":"33","author":"Prieto-Perez","year":"2020","journal-title":"Mod Pathol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207760","article-title":"Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination","volume":"75","author":"Attwell","year":"2022","journal-title":"J Clin Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-00187-5","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discovery"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury","volume":"7","author":"Liu","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30008","article-title":"IL-18 and infections: Is there a role for targeted therapies","volume":"236","author":"Vecchie","year":"2021","journal-title":"J Cell Physiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003816","article-title":"Association of elevated plasma interleukin-18 level with increased mortality in a clinical trial of statin treatment for acute respiratory distress syndrome","volume":"47","author":"Rogers","year":"2019","journal-title":"Crit Care Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1821111116","article-title":"Role for nuclear interleukin-37 in the suppression of innate immunity","volume":"116","author":"Li","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01434.x","article-title":"Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties","volume":"35","author":"Orlicky","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/all.15072","article-title":"IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33","volume":"77","author":"Schroder","year":"2022","journal-title":"Allergy"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13400","article-title":"The alpha-melanocyte-stimulating hormone acts as a local immune homeostasis factor in experimental allergic asthma","volume":"49","author":"Webering","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/all.15164","article-title":"The NLRP3 inflammasome inhibitor, OLT1177((R)), ameliorates experimental allergic asthma in mice","volume":"77","author":"Lunding","year":"2022","journal-title":"Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1427100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T04:45:05Z","timestamp":1719290705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1427100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2024.1427100"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1427100","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"article-number":"1427100"}}